Stock Market

A salesman carries a Best Buy shopping basket in San Francisco, California. Getty Images Check out the companies making headlines in midday trading. American Airlines, United Airlines, Carnival — Airlines and cruise stocks surged on Tuesday as stocks tied to an economic recovery continued to rise after a series of positive vaccine announcements. Shares of
0 Comments
Traders work on the floor of the New York Stock Exchange. NYSE The Dow Jones Industrial average’s rally through 30,000 could draw in sidelined cash and broaden market leadership, as investors bet on financials and other underperformers in addition to technology shares. The Dow rode to 30,000 from 20,000 with a big lift from technology.
0 Comments
Former Federal Reserve Board Chairwoman Janet Yellen Joshua Roberts | Reuters President-elect Joe Biden’s choice of Janet Yellen as Treasury Secretary was seen as a win for markets, since the former Federal Reserve chair should focus on fixing the economy rather than the progressive Democratic agenda feared by some investors. The first woman Fed chief
0 Comments
From Birch Gold Group In the past few weeks, we’ve looked into Joe Biden’s proposals for Social Security and 401(k) plans. We’ve also examined the potential impact of these proposals on retirement savers. Today, let’s take a look at the broader economic picture and, if Trump’s legal challenges aren’t successful, how Biden and his economic team might stand up to
0 Comments
Check out the companies making headlines midday Monday: AstraZeneca — Shares of British pharmaceutical giant AstraZeneca fell more than 3% after the company said clinical trials showed its coronavirus vaccine has an average efficacy of 70% in preventing the virus. Its competitors Pfizer and Moderna previously said their Covid-19 vaccine candidates were more than 90%
0 Comments
Three Weeks Ago: Related: Democrats overwhelmingly say fake news spread by Russia was at least somewhat likely to have affected the results of the presidential election – just under half (46%) say that it was very likely. Republicans disagree – except for those Republicans who think that Russian-sponsored spreading of fake news actually took place.
0 Comments
Merrill Lynch upgraded Carlyle’s rating to Buy from Hold and raised the stock’s price target to $35 (25.3% upside potential) from $30. Merrill Lynch analyst Michael Carrier said that “We believe the outlook for CG is attractive given the potential for FRE [fee-related earnings]/margin growth in 2H21-’23 as flagship funds re-enter the market, an improving
0 Comments
Shares of Eiger Biopharmaceuticals popped more than 12% in Friday’s extended market session after the US Food and Drug Administration (FDA) approved its Zokinvy (lonafarnib) capsules to reduce the risk of death in young patients suffering from Hutchinson-Gilford progeria syndrome (HGPS). Eiger (EIGR) said that the FDA approval of Zokinvy is also for the treatment of
0 Comments
by Dr. Eowyn UPDATE: Sidney Powell told TheBlaze TV host Glenn Beck: “We will start putting documents online and sending them to people like you, as soon as we possibly can. I would hope that we could start that by this weekend.” ————————————————————————————– The Trump campaign has charged voting irregularities in dozens of lawsuits since Election Day in a
0 Comments
Shares of FireEye jumped 16.7% in Thursday’s extended trading session after the cybersecurity solution provider revealed it received a capital investment from the Blackstone Group and announced the acquisition of Respond Software. Blackstone Tactical Opportunities and ClearSky have bought $400 million worth of FireEye’s (FEYE) 4.5% Series A Convertible preferred stock at a price of
0 Comments
by Martin Armstrong A massive protest has taken place today in Paris on Saturday, November 21, 2020. This is in Human Rights Square at Trocadero in Paris. Demonstrators were gathering to protest against the so-called ‘global security‘ bill in France. The ‘global security‘ bill, was approved on Friday evening by the French National Assembly. It
0 Comments
Eli Lilly and Incyte announced on Thursday that the FDA had granted Emergency Use Authorization (EUA) for the distribution and emergency use of baricitinib, its rheumatoid arthritis drug, in combination with Gilead’s remdesivir in hospitalized adult and pediatric patients aged two years or older with suspected or confirmed COVID-19 who require supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO).  This development
0 Comments
by Amy S.   Why is China Rising while America Declining ? The U.S. is in relative decline as the Chinese power is rapidly rising. There is a huge trade deficit with China and billions of dollars every year are flowing out of our country to them. $419.2 billion was the trade deficit in 2018, with
0 Comments
Shares of Mesoblast gained 17% after it announced an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of Mesoblast’s remestemcel-L. The initial focus is to develop a treatment for acute respiratory distress syndrome (ARDS), which is associated with COVID-19.  As per the terms of the agreement, Mesoblast (MESO) will
0 Comments